Wagner Wealth Management (South Carolina)’s Regeneron Pharmaceuticals REGN Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28	Closed	-$19K	–	608
2022 Q3	$19K	Hold	28	–	–	0.01%	326
2022 Q2	$17K	Buy	+28	New	+$18.2K	0.01%	355
2022 Q1	–	Sell	-25	Closed	-$16K	–	566
2021 Q4	$16K	Hold	25	–	–	0.01%	430
2021 Q3	$16K	Buy	+25	New	+$15.5K	0.01%	406
2021 Q2	–	Sell	-10	Closed	-$5K	–	713
2021 Q1	$5K	Buy	+10	New	+$4.87K	﹤0.01%	543
2018 Q2	–	Sell	-15	Closed	-$5K	–	704
2018 Q1	$5K	Hold	15	–	–	﹤0.01%	431
2017 Q4	$6K	Buy	+15	New	+$6.08K	﹤0.01%	493

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s REGN Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Regeneron Pharmaceuticals (REGN) in Q4 2022, closing a stake of 28 shares — an estimated $19K sold.

Wagner Wealth Management (South Carolina) first reported a position in REGN in Q4 2017 and held it in 7 quarters. The position peaked at $19K in Q3 2022. 1,158 funds tracked by Wall St. Rank hold REGN as of Q4 2022.

Wagner Wealth Management (South Carolina) reported no remaining Regeneron Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Wagner Wealth Management (South Carolina) sold 28 Regeneron Pharmaceuticals shares in Q4 2022, an estimated $19K.
Wagner Wealth Management (South Carolina) first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 7 quarters.
Wagner Wealth Management (South Carolina)'s Regeneron Pharmaceuticals position peaked at $19K in Q3 2022.
1,158 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.